Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Oruka Therapeutics, Inc. (ORKA) Receiveable Turnover data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-29.58M |
|
-- |
|
-- |
|
$34.43M |
|
$-34.43M |
|
$4.85M |
|
$-29.58M |
|
$-29.58M |
|
$-29.58M |
|
$-29.58M |
|
$-29.58M |
|
$-29.58M |
|
$-34.43M |
|
$-35.07M |
|
45.61M |
|
45.61M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$343.86M |
|
$0.29M |
|
$144.76M |
|
$488.62M |
|
$15.37M |
|
-- |
|
$1.31M |
|
$16.69M |
|
$469.00M |
|
$471.93M |
|
$471.93M |
|
48.72M |
|
| Cash Flow Statement Financials | |
$-88.21M |
|
$-96.75M |
|
$170.31M |
|
$61.58M |
|
$46.94M |
|
$-14.64M |
|
$24.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-88.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Receiveable Turnover |
-- |
-- |
|
-6.31% |
|
-6.27% |
|
-6.05% |
|
-6.27% |
|
$9.69 |
|
$-1.94 |
|
$-1.93 |
|